David S. Smith serves life sciences companies and their investors with strategic guidance on corporate governance, venture financings, intellectual property transactions and regulatory matters.
His corporate practice is concentrated in the organization, financing and growth of life sciences and healthcare technology companies and counseling of their management teams.
David’s intellectual property-related work includes IP transactions, regulatory issues and licensing. He is an authority on the legal issues surrounding the use of human biological materials and frequently speaks at universities and trade conferences on commercial development of tissue, cell and stem cell technologies.
David was senior vice president and general counsel of TissueInformatics.Inc, a bioinformatics company, until its merger with Icoria, Inc.
David is active in a number of trade organizations, and he serves on the board of the Foundation for Cell and Gene Medicine (formerly ARM Foundation for Regenerative Medicine Education and Research).
David is a former adjunct professor in Carnegie Mellon University’s Department of Engineering and Public Policy and member of the Scientific Advisory Board of Clinical Cell Culture, Ltd., a tissue engineering company listed on the Australian stock exchange. He is a past member of the board of directors of the Pennsylvania Biotechnology Association and secretary of the Pittsburgh Tissue Engineering Initiative.